000 | 01124 a2200337 4500 | ||
---|---|---|---|
005 | 20250517144121.0 | ||
264 | 0 | _c20180430 | |
008 | 201804s 0 0 eng d | ||
022 | _a1600-0404 | ||
024 | 7 |
_a10.1111/ane.12755 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aElkjaer, M L | |
245 | 0 | 0 |
_aTeriflunomide for multiple sclerosis in real-world setting. _h[electronic resource] |
260 |
_bActa neurologica Scandinavica _cNov 2017 |
||
300 |
_a447-453 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Observational Study | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAlanine Transaminase _xblood |
650 | 0 | 4 |
_aCrotonates _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydroxybutyrates |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xblood |
650 | 0 | 4 | _aNitriles |
650 | 0 | 4 |
_aToluidines _xadministration & dosage |
700 | 1 | _aMolnar, T | |
700 | 1 | _aIlles, Z | |
773 | 0 |
_tActa neurologica Scandinavica _gvol. 136 _gno. 5 _gp. 447-453 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/ane.12755 _zAvailable from publisher's website |
999 |
_c26995838 _d26995838 |